| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues, net | 70,809,635 | 80,417,622 | 96,033,055 | 138,684,814 |
| Cost of revenues (exclusive of depreciation and amortization, which is shown separately below) | 52,683,525 | 54,998,524 | 65,185,060 | 88,764,282 |
| General and administrative | 30,091,786 | 31,240,943 | 32,902,070 | 28,784,850 |
| Depreciation and amortization | 3,971,232 | 3,981,008 | 3,761,391 | 4,177,534 |
| Legal and regulatory | 5,727,008 | 4,351,974 | 4,210,823 | 3,295,139 |
| Technology and development | 3,193,480 | 2,957,203 | 3,639,444 | 3,145,834 |
| Sales, advertising and marketing | 380,172 | 368,214 | 331,705 | 379,778 |
| Finite-lived intangible asset impairment | 8,020,343 | - | - | - |
| Goodwill impairment | 8,718,398 | - | - | - |
| Total expenses | 112,785,944 | 97,897,866 | 110,030,493 | 128,547,417 |
| (loss) income from operations | -41,976,309 | -17,480,244 | -13,997,438 | 10,137,397 |
| Interest expense, net | -219,861 | -443,662 | -426,284 | -505,085 |
| Loss on change in fair value of contingent consideration | 1,052,394 | 0 | - | 44,520 |
| Loss on equity method investments | -27,035 | -38,817 | -40,698 | -82,742 |
| Gain (loss) on remeasurement of operating and finance leases | 5,077 | -6,607 | -40,837 | -6,163 |
| (loss) gain on disposal of fixed assets | -10,453 | -48,354 | 15,139 | -28,681 |
| Other income (expense) | 112,184 | 101,046 | -312,869 | -435,825 |
| Total other expense | -1,192,482 | -436,394 | -805,549 | -1,103,016 |
| Net (loss) income before income tax benefit (expense) | -43,168,791 | -17,916,638 | -14,802,987 | 9,034,381 |
| Benefit from (provision for) income taxes | -13,511,429 | -4,626,745 | -3,723,687 | 4,488,828 |
| Net (loss) income | -29,657,362 | -13,289,893 | -11,079,300 | 4,545,553 |
| Net loss attributable to noncontrolling interests | -1,888,976 | -2,134,647 | -1,673,985 | -952,348 |
| Net (loss) income attributable to stockholders of docgo inc. and subsidiaries | -27,768,386 | -11,155,246 | -9,405,315 | 5,497,901 |
| Unrealized gain on investments, net of tax | 31,734 | 76,733 | - | - |
| Foreign currency translation adjustment | -319,851 | 927,462 | 495,538 | 934,774 |
| Total comprehensive (loss) income | -28,056,503 | -10,151,051 | -8,909,777 | 6,432,675 |
| Net (loss) income per share attributable to docgo inc. and subsidiaries - basic (in dollars per share) | -0.28 | -0.11 | -0.09 | 0.05 |
| Net (loss) income per share attributable to docgo inc. and subsidiaries - diluted (in dollars per share) | -0.28 | -0.11 | -0.09 | 0.05 |
| Weighted-average shares outstanding - basic (in shares) | 97,808,976 | 98,931,293 | 101,594,579 | 102,067,579 |
| Weighted-average shares outstanding - diluted (in shares) | 97,808,976 | 98,931,293 | 101,594,579 | 106,290,929 |
DocGo Inc. (DCGO)
DocGo Inc. (DCGO)